Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo

References

• FurmanJMCassSPBenign paroxysmal positional vertigoN Engl J Med1999341211590159610564690
   PubMed Web of Science ®Google Scholar
• von BrevernMRadtkeALeziusFEpidemiology of benign paroxysmal positional vertigo: a population based studyJ Neurol Neurosurg Psychiatry200778771071517135456
   PubMed Web of Science ®Google Scholar
• BhattacharyyaNBaughRFOrvidasLClinical practice guideline: benign paroxysmal positional vertigoOtolaryngology-Head and Neck Surgery20081395_suppl478118585560
   PubMed Web of Science ®Google Scholar
• BalohRWHonrubiaVJacobsonKBenign positional vertigo: clinical and oculographic features in 240 casesNeurology19873733713783822129
   PubMed Web of Science ®Google Scholar
• Lopez-EscamezJAGamizMJFernandez-PerezAGomez-FiñanaMLong-term outcome and health-related quality of life in benign paroxysmal positional vertigoEur Arch Otorhinolaryngol2005262650751115942805
   PubMed Web of Science ®Google Scholar
• ImaiTItoMTakedaNNatural course of the remission of vertigo in patients with benign paroxysmal positional vertigoNeurology200564592092115753441
   PubMed Web of Science ®Google Scholar
• KerberKABurkeJFSkolarusLEUse of BPPV processes in emergency department dizziness presentations: a population-based studyOtolaryngol Head Neck Surg2013148342543023264119
   PubMed Web of Science ®Google Scholar
• HelminskiJOZeeDSJanssenIHainTCEffectiveness of particle repositioning maneuvers in the treatment of benign paroxysmal positional vertigo: a systematic reviewPhys Ther201090566367820338918
   PubMed Web of Science ®Google Scholar
• TirelliGNicastroLGattoATofanelliMRepeated canalith repositioning procedure in BPPV: Effects on recurrence and dizziness preventionAm J Otolaryngol2017381384327806891
   PubMed Web of Science ®Google Scholar
• SuPLiuYCLinHCRisk factors for the recurrence of post-semicircular canal benign paroxysmal positional vertigo after canalith repositioningJ Neurol20162631455126477026
   PubMed Web of Science ®Google Scholar
• LiJCJcLMastoid oscillation: a critical factor for success in canalith repositioning procedureOtolaryngol Head Neck Surg199511266706757777350
   PubMed Web of Science ®Google Scholar
• KimHALeeHAutonomic dysfunction as a possible cause of residual dizziness after successful treatment in benign paroxysmal positional vertigoClin Neurophysiol2014125360861424045026
   PubMed Web of Science ®Google Scholar
• MulavaraAPCohenHSPetersBTSangi-HaghpeykarHBloombergJJNew analyses of the sensory organization test compared to the clinical test of sensory integration and balance in patients with benign paroxysmal positional vertigoLaryngoscope201312392276228023553110
   PubMed Web of Science ®Google Scholar
• MandalàMSantoroGPAsprella LibonatiGDouble-blind randomized trial on short-term efficacy of the Semont maneuver for the treatment of posterior canal benign paroxysmal positional vertigoJ Neurol2012259588288522008871
   PubMed Web of Science ®Google Scholar
• JungHJKooJWKimCSKimJSSongJJAnxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigoActa Otolaryngol2012132327728422201336
   PubMed Web of Science ®Google Scholar
• DengWYangCXiongMFuXLaiHHuangWDanhong enhances recovery from residual dizziness after successful repositioning treatment in patients with benign paroxysmal positional vertigoAm J Otolaryngol201435675375725146349
   PubMed Web of Science ®Google Scholar
• GeLHanLHuangXGuanCBetahistine was effective on residual dizziness after successful repositioning treatment in BPPV patientsZhejiang Practical Medicine2015205329331
   Google Scholar
• MaDJHuJLuXXuJQEfficacy observation of different doses of betahistine in the treatment of benign paroxysmal positional vertigo with residual dizzinessChin J of Clinical Rational Drug Use2018115A2324
   Google Scholar
• BenjaminCLPuleoCMSettipaniCAHistory of cognitive-behavioral therapy in youthChild Adolesc Psychiatr Clin N Am201120217918921440849
   PubMed Web of Science ®Google Scholar
• HolmbergJKarlbergMHarlacherUMagnussonMOne-year follow-up of cognitive behavioral therapy for phobic postural vertigoJ Neurol200725491189119217676355
   PubMed Web of Science ®Google Scholar
• EdelmanSMahoneyAECremerPDCognitive behavior therapy for chronic subjective dizziness: a randomized, controlled trialAm J Otolaryngol201233439540122104568
   PubMed Web of Science ®Google Scholar
• YuYCXueHZhangYXZhouJCognitive behavior therapy as augmentation for sertraline in treating patients with persistent postural-perceptual dizzinessBiomed Res Int20182018851863129707579
   PubMed Web of Science ®Google Scholar
• ParnesLSAgrawalSKAtlasJDiagnosis and management of benign paroxysmal positional vertigo (BPPV)CMAJ2003169768169314517129
   PubMed Web of Science ®Google Scholar
• Otorhinolaryngology Branch of Chinese Medical AssociationDiagnosis and efficacy evaluation of benign paroxysmal positional vertigoChin J Otorhinolaryngol Head Neck Surg2007423163164
   Google Scholar
• EpleyJMThe canalith repositioning procedure: for treatment of benign paroxysmal positional vertigoOtolaryngol Head Neck Surg199210733994041408225
   PubMed Web of Science ®Google Scholar
• JacobsonGPNewmanCWThe development of the dizziness handicap inventoryArch Otolaryngol Head Neck Surg199011644244272317323
   PubMedGoogle Scholar
• CheTTengXHuangQAgomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trialNeuropsychiatr Dis Treat2018141527153329942131
   PubMed Web of Science ®Google Scholar
• LacourMvan de HeyningPHNovotnyMTighiletBBetahistine in the treatment of Ménière’s diseaseNeuropsychiatr Dis Treat20073442944019300572
   PubMedGoogle Scholar
• DingXGuHLuoJLiJClinical observation of betahistine in the treatment of 80 cases of vertigoMod Diagn Treat2013241534333434
   Google Scholar
• GuoKTherapeutic effect of betahistine on clinical symptoms and adverse events in patients with vertigoMedical Theory and Practice2018314521522
   Google Scholar
• Jeck-TholeSWagnerWBetahistineDrug Safety200629111049105917061910
   PubMed Web of Science ®Google Scholar
• BertlichMIhlerFWeissBGRole of capillary pericytes and precapillary arterioles in the vascular mechanism of betahistine in a guinea pig inner ear modelLife Sci2017187172128818391
   PubMed Web of Science ®Google Scholar
• MøllerMNKirkebySVikesåJNielsenFCCaye-ThomasenPExpression of histamine receptors in the human endolymphatic sac: the molecular rationale for betahistine use in Menieres diseaseEur Arch Otorhinolaryngol201627371705171026208913
   PubMed Web of Science ®Google Scholar
• MataDARamosMABansalNPrevalence of depression and depressive symptoms among resident physicians: a systematic review and meta-analysisJAMA2015314222373238326647259
   PubMed Web of Science ®Google Scholar
• ChenJJZhengPLiuYYSex differences in gut microbiota in patients with major depressive disorderNeuropsychiatr Dis Treat20181464765529520144
   PubMed Web of Science ®Google Scholar
• LinLChenXMLiuRHNovel urinary metabolite signature for diagnosing postpartum depressionNeuropsychiatr Dis Treat2017131263127028546751
   PubMed Web of Science ®Google Scholar
• ChenJJBaiSJLiWWUrinary biomarker panel for diagnosing patients with depression and anxiety disordersTransl Psychiatry20188119230232320
   PubMed Web of Science ®Google Scholar